Academic background&position

data loading...

1. [SCIE] mTOR downregulation promotes anti-inflammatory responses via the CCL3-CCR5 axis in hypoxic retinopathy [MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT] - 2025-03-13
2. [SCIE] Cross-species RNAi therapy via AAV delivery alleviates neuropathic pain by targeting GCH1 [NEUROTHERAPEUTICS] - 2025-03-01
3. [SCIE] mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy [PLoS One] - 2022-06-16
4. [SCIE] Microglial deactivation by adeno-associated virus expressing small-hairpin GCH1 has protective effects against neuropathic pain development in a spinothalamic tract-lesion model [CNS Neuroscience & Therapeutics] - 2022-01-15
5. [SCIE] AAV expressing an mTOR-inhibiting siRNA exhibits therapeutic potential in retinal vascular disorders by preserving endothelial integrity [FEBS OPEN BIO] - 2022-01-10